Sign Out
Adjuvant treatment of postmenopausal women with hormone receptor positive primary breast cancer.
Extended adjuvant treatment of hormone dependent primary breast cancer in postmenopausal women who have received prior standard adjuvant Tamoxifen therapy for 5 years.
First-line treatment of hormone dependent advanced breast cancer in postmenopausal women.
Treatment of advanced breast cancer after relapse or disease progression in women with natural or artificially induced postmenopausal status, who have previously been treated with anti-oestrogens.
Efficacy has not been demonstrated in patients with hormone receptor negative breast cancer.
Continue with Google